SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

PMN

ProMIS Neurosciences, Inc.
NASDAQHealth Care

Latest close: 8.15 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 13, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 5, 2026Reported purchase · Form 4Johanne Kaplan, Chief Development Officer · $30.3KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record29123 flagged findings
Reported transactions (Form 4)80since Jul 31, 2024 · and 39 other holdings
Corporate events (8-K)30since Sep 13, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…because they are a freestanding financial instrument, are immediately exercisable, do not embody an obligation for the…”
    +1 more passage from the same document
    • “…to purchase 39,389 Common Shares (the “ RD Pre-funded Warrant ”) to such investor (the “ RD Offering ”). The RD Pre-funded…”
  • 2026-05-12capital return (buybacks/dividends)recentOpen filing ↗
    “…immediately after giving effect to such exercise. ​ The Company determined the July 22, 2025 Warrant met the permanent equity…”
    +1 more passage from the same document
    • “…after giving effect to such exercise. ​ The Company determined the July 28, 2025 Warrants met the permanent equity criteria…”
  • 2026-03-25share offering or dilution eventrecentOpen filing ↗
    “…dividends were pain in full. The Company does not have any outstanding Preferred Shares. Registration Rights Certain of the…”
    +1 more passage from the same document
    • “…dividends were pain in full. The Company does not have any outstanding Preferred Shares.. Registration Rights Certain of the…”
  • 2026-03-25capital return (buybacks/dividends)recentOpen filing ↗
    “…capital and other general corporate expenses. General corporate purposes may include capital expenditures, research and…”
  • 2026-03-25merger or acquisition eventrecentOpen filing ↗
    “…at the next meeting of shareholders, and the shareholders may, by ordinary resolution, confirm, reject or amend the by-law,…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:25 on Nov 28, 2025) · 1:25 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 291)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 6, 26Form 4 ↗Insider transaction
  • Oct 6, 26Form 3 ↗Insider transaction
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Great Point Partners, LLC · 7.7% · event on Jun 30, 26 · amendment
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. · 7.8% · event on Jun 30, 26 · amendment
  • Aug 13, 268-K ↗Current report · Results
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Wellington Management Group LLP · 7.8% · event on Jun 30, 26 · amendment
  • Aug 7, 26Form 4 ↗Insider transaction
  • Jul 28, 268-K ↗Current report · Communication to the market · Other events
  • Insider transaction · 9 Form 4 filingsshow all 9hide
  • May 20, 268-K ↗Current report · A senior executive left or was appointed
  • May 15, 26SCHEDULE 13G ↗Passive stake · Great Point Partners, LLC · 10.0% · event on Mar 31, 26
  • May 15, 26SCHEDULE 13G ↗Passive stake · Wellington Management Group LLP · 10.0% · event on Mar 31, 26
  • May 12, 2610-Q ↗Quarterly report
  • May 12, 268-K ↗Current report · Results
  • May 7, 26SCHEDULE 13G/A ↗Passive stake · Michael S. Gordon · 2.0% · event on Mar 31, 26 · amendment
  • Apr 23, 26Form 4 ↗Insider transaction

291 filings on record, the oldest from Feb 28, 22.

Listing the 25 most recent filings of the 291 on record.

8-Ks, explained

Stress2Structure18Governance11
  • May 20, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 30, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Oct 24, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Sep 30, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Structure4 material agreements entered2025show all 4hide
    • Aug 19, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Jul 28, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jul 22, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Jul 22, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jun 13, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 19, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 8, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 10, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 26, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jul 5, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 5, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

7 older filings not shown · The record reaches back to Jul 29, 22.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Fan Yu17.0%Feb 3, 26SCHEDULE 13D/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum.
  • ABG Management Ltd.11.3%Jan 29, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • JANUS HENDERSON GROUP PLC14.4%Mar 31, 26SCHEDULE 13G ↗
  • Deep Track Capital, LP10.0%Jan 30, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Trails Edge Capital Partners, LP9.9%Feb 3, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.7.8%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
  • Wellington Management Group LLP7.8%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 4 more holdershide
  • Sphera Funds Management Ltd.7.8%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Great Point Partners, LLC7.7%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Michael S. Gordon2.0%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Armistice Capital, LLC0.9%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 5, 26Buy$30KJohanne KaplanChief Development Officer↗
  • Apr 22, 26Buy$45KPatrick D. Kirwin↗
  • Mar 5, 26Buy$49KEugene Williams↗
  • Mar 4, 26Buy$48KEugene Williams↗
  • Mar 3, 26Buy$22KEugene Williams↗
  • Mar 2, 26Buy$23KEugene Williams↗
  • Feb 19, 26Buy$25KJohanne KaplanChief Development Officer↗
  • Feb 3, 26Buy$8.5MABG Management Ltd.↗
  • Oct 3, 25Buy$15KMax A. Milbury↗
  • Jun 30, 25Sellamount n/aMICHAEL S GORDON↗
  • Feb 10, 25Buy$15KNeil CashmanChief Scientific Officer↗
  • Sep 24, 24Buy$91KMadge K. Shafmaster↗

There are 8 more transactions in this stretch.

Stock compensation, tax and giftsshow the 20 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Feb 3, 26Compensation$37KPatrick D. Kirwin↗
  • Feb 3, 26Compensation$80KMax A. Milbury↗
  • Feb 3, 26Compensation$75KNeil K WarmaChief Executive Officer↗
  • Feb 3, 26Compensation$25KJohanne KaplanChief Development Officer↗
  • Feb 3, 26Compensation$50KNeil CashmanChief Scientific Officer↗
  • Jul 25, 25Otheramount n/a19 Promis Title↗
  • Jul 25, 25Otheramount n/a19 Promis Title↗
  • Jul 25, 25Otheramount n/a19 Promis Title↗
  • Jul 25, 25Otheramount n/aMICHAEL S GORDON↗
  • Jul 25, 25Otheramount n/aMICHAEL S GORDON↗
  • Jul 25, 25Otheramount n/aMICHAEL S GORDON↗
  • Jul 25, 25Otheramount n/aJeremy M. Sclar↗
  • Jul 25, 25Otheramount n/aJeremy M. Sclar↗
  • Jul 25, 25Otheramount n/aJeremy M. Sclar↗
  • Jul 25, 25Otheramount n/aJeremy M. Sclar 2012 Irrevocable Family Trust↗
  • Jul 25, 25Otheramount n/aJeremy M. Sclar 2012 Irrevocable Family Trust↗
  • Jul 25, 25Otheramount n/aJeremy M. Sclar 2012 Irrevocable Family Trust↗
  • Mar 13, 25Otheramount n/aMICHAEL S GORDON↗
  • Jul 31, 24Otheramount n/aMICHAEL S GORDON↗
  • Jul 31, 24Otheramount n/a19 Promis Title↗

The full record holds 47 transactions and goes back to Oct 11, 22.

Its sector and its market

ProMIS Neurosciences, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From ProMIS Neurosciences, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow ProMIS Neurosciences, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
291 documents on file, from Feb 28, 2022 to Oct 6, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.